Sandra Rosenbaum‐Krumme

1.1k total citations
24 papers, 779 citations indexed

About

Sandra Rosenbaum‐Krumme is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Sandra Rosenbaum‐Krumme has authored 24 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Sandra Rosenbaum‐Krumme's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Medical Imaging Techniques and Applications (11 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Sandra Rosenbaum‐Krumme is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Medical Imaging Techniques and Applications (11 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Sandra Rosenbaum‐Krumme collaborates with scholars based in Germany, Netherlands and United States. Sandra Rosenbaum‐Krumme's co-authors include Andreas Bockisch, Thorsten D. Poeppel, Walter Jentzen, Ina Binse, Susanne Lütje, Martin Gotthardt, Gerald Antoch, Rainer Görges, Sebastiaan A. M. W. van den Broek and Sandra Heskamp and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Nature Reviews Endocrinology and Theranostics.

In The Last Decade

Sandra Rosenbaum‐Krumme

23 papers receiving 758 citations

Peers

Countries citing papers authored by Sandra Rosenbaum‐Krumme

Since Specialization

Citations

This map shows the geographic impact of Sandra Rosenbaum‐Krumme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Rosenbaum‐Krumme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Rosenbaum‐Krumme more than expected).

Fields of papers citing papers by Sandra Rosenbaum‐Krumme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Rosenbaum‐Krumme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Rosenbaum‐Krumme. The network helps show where Sandra Rosenbaum‐Krumme may publish in the future.

Co-authorship network of co-authors of Sandra Rosenbaum‐Krumme

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Rosenbaum‐Krumme. A scholar is included among the top collaborators of Sandra Rosenbaum‐Krumme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Rosenbaum‐Krumme. Sandra Rosenbaum‐Krumme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Level of Agreement Between Pretherapeutic ¹²⁴I PET and Intratherapeutic ¹³¹I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases 2016 ·Journal of Nuclear Medicine ·Marcus Ruhlmann, Walter Jentzen, Verena Ruhlmann, Cinzia Pettinato, Gloria Rossi, Ina Binse, Andreas Bockisch, Sandra Rosenbaum‐Krumme	32
2	Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT 2016 ·Clinical Nuclear Medicine ·Susanne Lütje, (unknown), (unknown), Lale Umutlu, Martin Gotthardt, Thorsten D. Poeppel, Andreas Bockisch, Sandra Rosenbaum‐Krumme	62
3	⁶⁸Ga-DOTATOC PET/CT in Patients with Iodine- and ¹⁸F-FDG–Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin 2016 ·Journal of Nuclear Medicine ·Ina Binse, Thorsten D. Poeppel, Marcus Ruhlmann, Samer Ezziddin, Rainer Görges, Amir Sabet, Karsten Beiderwellen, Andreas Bockisch, Sandra Rosenbaum‐Krumme	25
4	Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Amir Sabet, Ina Binse, Semih Doğan, Andrea Koch, Sandra Rosenbaum‐Krumme, Hans‐Jürgen Biersack, Kim Biermann, Samer Ezziddin	14
5	Initial [18F]FDG PET/CT in high-risk DTC patients 2016 ·Nuklearmedizin - NuclearMedicine ·Ina Binse, Andreas Bockisch, Sandra Rosenbaum‐Krumme, Marcus Ruhlmann	7
6	Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative 124I-NaI-PET/CT in patients with papillary thyroid cancer 2016 ·European Journal of Nuclear Medicine and Molecular Imaging ·Amir Sabet, Ina Binse, Hong Grafe, Samer Ezziddin, Rainer Görges, Thorsten D. Poeppel, Andreas Bockisch, Sandra Rosenbaum‐Krumme	4
7	Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT? 2015 ·Nuclear Medicine Communications ·Benedikt M. Schaarschmidt, Johannes Grueneisen, Philipp Heusch, Benedikt Gomez, Lale Umutlu, Verena Ruhlmann, Sandra Rosenbaum‐Krumme, Gerald Antoch, Christian Buchbender	19
8	PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status 2015 ·Theranostics ·Susanne Lütje, Sandra Heskamp, (unknown), Thorsten D. Poeppel, Sebastiaan A. M. W. van den Broek, Sandra Rosenbaum‐Krumme, Andreas Bockisch, Martin Gotthardt, Mark Rijpkema, Otto C. Boerman	175
9	Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using ¹²⁴I PET Imaging 2014 ·Journal of Nuclear Medicine ·Walter Jentzen, (unknown), (unknown), (unknown), (unknown), Thorsten D. Poeppel, James Nagarajah, Wolfgang Brandau, Andreas Bockisch, Sandra Rosenbaum‐Krumme	56
10	Ethnicity, Clothing Style, and Body Mass Index are Significant Predictors of Vitamin D Insufficiency in Germany 2014 ·Endocrine Practice ·(unknown), James Nagarajah, (unknown), (unknown), (unknown), Sandra Rosenbaum‐Krumme, Andreas Bockisch, Seyed Rasoul Zakavi	24
11	Whole-body [18F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results 2014 ·European Radiology ·Karsten Beiderwellen, M. Huebner, Philipp Heusch, Johannes Grueneisen, Verena Ruhlmann, Felix Nensa, Hilmar Kuehl, Lale Umutlu, Sandra Rosenbaum‐Krumme, Thomas C. Lauenstein	67
12	The effect of radioiodine therapy after total thyroidectomy 2013 ·Nature Reviews Endocrinology ·Andreas Bockisch, Sandra Rosenbaum‐Krumme	2
13	Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies 2012 ·Annals of Nuclear Medicine ·Verena Hartung-Knemeyer, James Nagarajah, Walter Jentzen, Marcus Ruhlmann, Lutz S. Freudenberg, Alexander Stahl, Andreas Bockisch, Sandra Rosenbaum‐Krumme	15
14	Malignant Pheochromocytoma Imaging with [¹²⁴I]mIBG PET/MR 2012 ·The Journal of Clinical Endocrinology & Metabolism ·Verena Hartung-Knemeyer, Sandra Rosenbaum‐Krumme, Christian Buchbender, Thorsten Pöppel, Wolfgang Brandau, Walter Jentzen, Gerald Antoch, Michael Forsting, Andreas Bockisch, Hilmar Kühl	31
15	Effects of Rosiglitazone on Radioiodine Negative and Progressive Differentiated Thyroid Carcinoma as Assessed by 124I PET/CT Imaging 2012 ·Clinical Nuclear Medicine ·Sandra Rosenbaum‐Krumme, Lutz S. Freudenberg, Walter Jentzen, Andreas Bockisch, James Nagarajah	20
16	Diagnostic Accuracy of Virtual ¹⁸F-FDG PET/CT Bronchoscopy for the Detection of Lymph Node Metastases in Non–Small Cell Lung Cancer Patients 2011 ·Journal of Nuclear Medicine ·(unknown), Jon Treffert, Bernhard Geiger, (unknown), Verena Hartung, Sandra Rosenbaum‐Krumme, Michael Forsting, Gerald Antoch, Till A. Heusner	6
17	Diagnosis and dosimetry in differentiated thyroid carcinoma using 124I PET: comparison of PET/MRI vs PET/CT of the neck 2011 ·European Journal of Nuclear Medicine and Molecular Imaging ·James Nagarajah, Walter Jentzen, Verena Hartung, Sandra Rosenbaum‐Krumme, (unknown), Till A. Heusner, Gerald Antoch, Andreas Bockisch, Alexander Stahl	27
18	Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer 2011 ·European Journal of Nuclear Medicine and Molecular Imaging ·Lutz S. Freudenberg, Walter Jentzen, Alexander Stahl, Andreas Bockisch, Sandra Rosenbaum‐Krumme	45
19	Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography 2008 ·Nuclear Medicine Communications ·Hilmar Kuehl, Sandra Rosenbaum‐Krumme, Patrick Veit‐Haibach, H Stergar, Michael Forsting, Andreas Bockisch, Gerald Antoch	15
20	Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: Initial results 2008 ·European Journal of Radiology ·Hilmar Kuehl, Gerald Antoch, H Stergar, Patrick Veit‐Haibach, Sandra Rosenbaum‐Krumme, Florian Vogt, Andrea Frilling, Jörg Barkhausen, Andreas Bockisch	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact